Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: being younger and getting less benefit from adjuvant tamoxifen treatment

被引:0
|
作者
Yu, K. [1 ]
Di, G. [1 ]
Wu, J. [1 ]
Lu, J. [1 ]
Shen, K. [1 ]
Shen, Z. [1 ]
Shao, Z. [1 ]
机构
[1] Fudan Univ, Canc Hosp Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China
来源
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词
D O I
10.1016/S1359-6349(08)70759-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
  • [11] EFFECT OF ADJUVANT ENDOCRINE THERAPY ON ESTROGEN RECEPTOR-NEGATIVE, PROGESTERONE RECEPTOR-POSITIVE AND HER2 NEGATIVE BREAST CANCER PATIENTS
    Shen, Jun
    Wang, Lin-bo
    Teng, Rong-yue
    Shen, Jian-guo
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 1595 - 1600
  • [12] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist?
    De Maeyer, Leen
    Van Limbergen, Erik
    De Nys, Katelijne
    Moerman, Philippe
    Pochet, Nathalie
    Hendrickx, Wouter
    Wildiers, Hans
    Paridaens, Robert
    Smeets, Ann
    Christiaens, Marie-Rose
    Vergote, Ignace
    Leunen, Karin
    Amant, Frederic
    Neven, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 335 - 336
  • [13] Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply
    Henderson, IC
    Norton, L
    Berry, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4465 - 4466
  • [14] The Clinicopathologic Characteristics and Clinical Outcomes of Estrogen Receptor-Negative and Progesterone Receptor-Positive Breast Cancer
    Kang, S.
    Jeon, Y.
    Kim, C.
    Cho, Y.
    Lee, S.
    CANCER RESEARCH, 2009, 69 (24) : 724S - 725S
  • [15] Tamoxifen for patients with estrogen receptor-negative breast cancer
    Swain, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 93S - 97S
  • [16] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [17] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [18] Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers
    Fei, Fei
    Siegal, Gene P.
    Wei, Shi
    CLINICAL BREAST CANCER, 2022, 22 (07) : E788 - E797
  • [19] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist? Reply
    Rakha, Emad A.
    Ellis, Ian O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 336 - 338
  • [20] Estrogen receptor-negative, progesterone receptor-positive breast carcinoma - Poor clinical outcome
    Keshgegian, AA
    Cnaan, A
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (10) : 970 - 973